Latest breakthrough bleeding Stories

2011-05-02 05:45:00

PARSIPPANY, N.J., May 2, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), today announced the U.S. commercial launch of Generess(TM) Fe (norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate chewable tablets) 0.8 mg/25 mcg, a new low-dose oral contraceptive option that's highly effective at preventing pregnancy and proven to provide users with short, lighter, predictable periods. (Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO) Generess Fe...

2010-12-22 15:26:00

MORRISTOWN, N.J., Dec. 22, 2010 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals (NYSE: WPI) today announced the U.S. Food and Drug Administration (FDA) approval of a novel oral contraceptive product - the first and only low dose oral contraceptive to combine 0.8 mg norethindrone and 0.025 mg ethinyl estradiol in chewable form, with four 75 mg ferrous fumarate (iron) placebo tablets. Taken orally, once daily, the product is proven effective in lowering the risk of pregnancy. Watson's new...

2009-05-05 11:00:00

CHICAGO, May 5 /PRNewswire/ -- The birth control pill ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol) is associated with fewer mean days of unscheduled bleeding than another popular birth control pill, YAZ(R) (drospirenone/ethinyl estradiol), in healthy, sexually active women, according to a study presented today at the 57th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG)(1). Historical reviews have estimated that at least one third...

2006-08-23 16:32:39

NEW YORK (Reuters Health) - After having a cesarean delivery, a woman may experience vaginal bleeding outside her normal periods. Taking oral contraceptive pills can resolve the problem, researchers in Japan report. Anatomic defects at the site of cesarean section scars in the uterus are thought to be the cause of such bleeding, they explain. However, there is currently no simple treatment. Dr. Masahiro Tahara from Osaka University Graduate School of Medicine and colleagues evaluated...

2005-07-11 12:28:13

By Richard Woodman LONDON (Reuters Health) - Drug maker GlaxoSmithKline has issued a "Dear Doctor" letter advising that its anti-epilepsy drug Lamictal (lamotrigine) can reduce the effectiveness of oral contraceptives. New data have demonstrated an interaction between combined oral contraceptives and lamotrigine which could lead to reduced effectiveness of hormonal contraceptives, a revised product label states. "Women should have a review of their contraception when starting lamotrigine,...

Word of the Day
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.